GSK3 and tau: two convergence points in Alzheimer's disease.
about
Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future ConcernsNebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signalingGSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinCoffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cellsThe combination effects of licl and the active leflunomide metabolite, A771726, on viral-induced interleukin 6 production and EV-A71 replicationIntranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice.Phosphokinase antibody arrays on dendron-coated surface.Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model.Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice.A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons.esyN: network building, sharing and publishingThe spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling.Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice.Treadmill exercise decreases incidence of Alzheimer's disease by suppressing glycogen synthase kinase-3β expression in streptozotocin-induced diabetic rats.Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesGSK3β Interactions with Amyloid Genes: An Autopsy Verification and ExtensionAcute Ethanol Inhibition of γ Oscillations Is Mediated by Akt and GSK3βAmyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damageEarly glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathwayGlycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer's disease.Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesisInsulin dysfunction and Tau pathology.Protein phosphorylation in neurodegeneration: friend or foe?Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.Aberrant Wnt signaling: a special focus in CNS diseases.The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells.Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.Diversity-Oriented Synthesis as a Strategy for Fragment Evolution against GSK3βIn vivo regulation of glycogen synthase kinase 3β activity in neurons and brainsIn vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.Adrenomedullin Contributes to Age-Related Memory Loss in Mice and Is Elevated in Aging Human Brains.Anti-inflammatory and anti-oxidative effects of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on β-amyloid-induced microglial activation.Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.
P2860
Q26745513-0F25615A-7469-4E8C-A70E-E82EB225A8F5Q27320509-4E8FA35C-F491-416E-B80E-2A9BDE35334DQ27331743-B2E830DE-A903-44B2-8EEA-75CE53DF5AC4Q28385402-17AE4AE1-30B6-4B4B-8357-FB6F13CCB266Q28545087-AF0020BB-8A11-49E1-AEAC-59CF10724449Q30362847-35A79A02-A711-4481-A36A-5521664821E2Q33573142-B53EAF6F-0545-4AD4-A5B1-76E75C25A703Q33603862-B52FCF55-0392-481B-AC8C-F4AD13DA13BCQ33766526-0F254CE1-3566-4AAC-BFE4-6B21921F3CC7Q33999486-0236736C-A169-4256-8871-EFD19DAFB186Q34094965-0B327E61-80FB-41A8-A5A2-A31584142832Q34436467-601206FC-03A2-472B-AE6E-59B2F33C5686Q34444298-0EBCE0C4-BEDC-456D-8A1C-13A7A91B91B0Q34735544-3C02B793-F505-4786-B733-F45EB5431B87Q35128111-72DCC9AC-377A-4633-A022-DF519FF4E276Q35557574-7DD1999B-6459-45AC-A328-0FF3DC341F0DQ35576517-920D3EEB-00BB-41C9-A8C3-FDA983963A8CQ35776248-1FF4E005-A900-4FBC-A50D-6995705444C9Q35800000-939DD879-C12F-4B71-9832-3288F6A0274AQ35854093-C06BC711-DFA5-4CB8-9858-D4499FDCA486Q36224340-48D25BBA-8D2B-4764-93AC-35DF5959F5E0Q37180745-03EFF84B-180E-4E2B-8432-3C4E73F4BA90Q37302845-D1A531BA-DC90-4FE7-BBA2-617B68D07660Q37384934-8095976D-1FAE-418F-956D-A84D12296AACQ37642163-2481FDA1-7692-4704-BD20-D17FF3642F51Q37690524-36DAC0BD-0130-47AC-B77C-CDB1660D06F6Q38191590-B58787E3-DAEB-42B2-9F0D-BB392B35EFEDQ38214594-5B54DC20-C4FA-4C51-A37F-633932B0BC31Q38891752-253AD7FD-4FB6-47B5-B8E4-55BB40F96FDCQ38994300-430611ED-03FA-4B0E-8673-8D5D4296BBDFQ39387696-E6983762-F474-416A-9FC4-B7FF86581F0AQ40990185-7EC51348-CF8A-40CC-A188-5001A091D6B7Q41026207-E45F8352-705A-4F67-AD39-8338D66F3D63Q41063986-88A750F7-B572-44E9-B0DF-463F57D774EDQ41447595-5FC5D527-D85C-4F37-AF10-8A71664D2D5FQ42762188-7F8E0742-8FEF-41CB-A4A1-6ABE706BB72AQ45406965-45DB7527-587F-42F0-AFBF-88195D43AFA9Q47609268-BCF1E358-0005-4DFF-8219-0032905CF21AQ52574481-3652A4C3-7BD7-4F64-8535-D016A5CA46A7Q55353865-ED854773-9FA5-4F8B-8848-4E0163111177
P2860
GSK3 and tau: two convergence points in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
GSK3 and tau: two convergence points in Alzheimer's disease.
@en
type
label
GSK3 and tau: two convergence points in Alzheimer's disease.
@en
prefLabel
GSK3 and tau: two convergence points in Alzheimer's disease.
@en
P2093
P50
P356
P1476
GSK3 and tau: two convergence points in Alzheimer's disease
@en
P2093
Felix Hernandez
Jesus Avila
Jose J Lucas
P304
P356
10.3233/JAD-2012-129025
P478
33 Suppl 1
P577
2013-01-01T00:00:00Z